Myriad Genetics buy Raymond James
Start price
07.05.25
/
50%
€4.12
Target price
07.05.26
€8.82
Performance (%)
23.79%
Price
07:32
?
Summary
This prediction is currently active. The prediction currently has a performance of 23.79%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | 1.224% | 1.224% |
| iShares Core DAX® | 0.998% | 0.948% |
| iShares Nasdaq 100 | 1.965% | 4.491% |
| iShares Nikkei 225® | 4.258% | 8.018% |
| iShares S&P 500 | 2.037% | 3.420% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its "outperform" rating re-affirmed by analysts at Raymond James. They now have a $10.00 price target on the stock, down previously from $19.00.
Ratings data for MYGN provided by MarketBeat